Data as of Sep 30
| +0.65 / +0.20%|
The 18 analysts offering 12-month price forecasts for Biogen Idec Inc have a median target of 388.00, with a high estimate of 474.00 and a low estimate of 314.00. The median estimate represents a +17.29% increase from the last price of 330.81.
The current consensus among 23 polled investment analysts is to Buy stock in Biogen Idec Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.